The LINQ II™ insertable cardiac monitoring system is the world's most accurate ICM,1-4 personalized for the patient's lifestyle and customized for the clinician's workflow. LINQ II ICM is ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.Product Details
The Reveal LINQ™ insertable cardiac monitor (ICM) with TruRhythm™ Detection is the world's smallest, most accurate ICM.1-6 Reveal LINQ ICM provides up to 3 years of cardiac monitoring and is MR Conditional at 1.5 and 3.0 Tesla with no post-insertion waiting period.†7Product Details
Reveal LINQ ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the Reveal LINQ ICM Clinician Manual or MRI Technical Manual for more details.
Reveal XT ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please note that patients must wait 6 weeks post-insertion before having an MRI scan. Please see the Reveal XT ICM Clinician Manual or MRI Checklist for more details.
Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.
Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
Biotronik BioMonitor 2 Technical Manual. 2017.
Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328.
ICM Size Comparison Guide. Medtronic data on file. 2019.
ICM Accuracy Comparison Guide. Medtronic data on file. 2019.
Refer to the Reveal LINQ ICM Clinician Manual for usage parameters.
Reference the Reveal XT ICM Clinician Manual for usage parameters.